Faculty of Physics and Center for NanoScience, Ludwig Maximilian University, Munich, Germany.
Biophys J. 2013 Sep 3;105(5):1208-16. doi: 10.1016/j.bpj.2013.07.037.
Von Willebrand Factor (VWF) is a multimeric protein crucial for hemostasis. Under shear flow, it acts as a mechanosensor responding with a size-dependent globule-stretch transition to increasing shear rates. Here, we quantify for the first time, to our knowledge, the size distribution of recombinant VWF and VWF-eGFP using a multilateral approach that involves quantitative gel analysis, fluorescence correlation spectroscopy, and total internal reflection fluorescence microscopy. We find an exponentially decaying size distribution of multimers for recombinant VWF as well as for VWF derived from blood samples in accordance with the notion of a step-growth polymerization process during VWF biosynthesis. The distribution is solely described by the extent of polymerization, which was found to be reduced in the case of the pathologically relevant mutant VWF-IIC. The VWF-specific protease ADAMTS13 systematically shifts the VWF size distribution toward smaller sizes. This dynamic evolution is monitored using fluorescence correlation spectroscopy and compared to a computer simulation of a random cleavage process relating ADAMTS13 concentration to the degree of VWF breakdown. Quantitative assessment of VWF size distribution in terms of an exponential might prove to be useful both as a valuable biophysical characterization and as a possible disease indicator for clinical applications.
血管性血友病因子(VWF)是一种重要的多聚体蛋白,在止血中发挥作用。在切变流中,它作为一种机械感受器,对不断增加的切变率表现出大小依赖性的球-延伸转变。在这里,我们首次定量地描述了重组 VWF 和 VWF-eGFP 的大小分布,采用了一种多边方法,该方法涉及定量凝胶分析、荧光相关光谱和全内反射荧光显微镜。我们发现重组 VWF 和源自血液样本的 VWF 的多聚体大小分布呈指数衰减,这与 VWF 生物合成过程中的逐步增长聚合过程的概念一致。该分布仅由聚合度来描述,在病理相关的突变 VWF-IIC 情况下,聚合度降低。血管性血友病因子特异性蛋白酶 ADAMTS13 系统地将 VWF 大小分布向较小的尺寸转移。这种动态演变使用荧光相关光谱进行监测,并与 ADAMTS13 浓度与 VWF 降解程度相关的随机切割过程的计算机模拟进行比较。用指数来定量评估 VWF 大小分布可能在生物物理特性分析和临床应用中的疾病指标方面都非常有用。